Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis

This publication has 49 references indexed in Scilit:

• Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis
  PLOS ONE, 2013
• Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
  Clinical Interventions in Aging, 2013
• Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence
  Clinical Microbiology and Infection, 2013
• Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock
  International Journal of Antimicrobial Agents, 2013
• Perioperative Pharmacology: A Focus on Vancomycin
  AORN Journal, 2011
• Clinical Outcomes of Linezolid vs Vancomycin in Methicillin-Resistant Staphylococcus aureus Ventilator-Associated Pneumonia
  Journal of Intensive Care Medicine, 2011
• Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
  Antimicrobial Agents and Chemotherapy, 2008
• Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
  Antimicrobial Agents and Chemotherapy, 2008
• Outcome of Vancomycin Treatment in Patients with Methicillin-SusceptibleStaphylococcus aureusBacteremia
  Antimicrobial Agents and Chemotherapy, 2008
• Measuring inconsistency in meta-analyses
  BMJ, 2003